Fluoroquinolones such as ciprofloxacin, levofloxacin, and moxifloxacin carry an aromatic fluorine and a piperazine side chain on a 4-oxo-3-quinolone carboxylic acid core. Industrial synthesis builds that core through three high-temperature nucleophilic steps, and dimethyl sulfoxide (DMSO) is the dominant solvent for each. Its boiling point near 190 °C, dipolar aprotic character, and ability to dissolve potassium fluoride make it effectively irreplaceable at the key fluorination stage.
Where DMSO Is Used in Fluoroquinolone Routes
The defining transformation is the Halex step, replacement of an aromatic chlorine by fluorine using anhydrous potassium fluoride. In DMSO, spray-dried KF dissolves at 150–200 °C to release a bare fluoride that is far more nucleophilic than in protic media, with rate enhancements of up to 10⁵-fold over amide solvents such as DMF. The KCl byproduct precipitates as the reaction proceeds and is removed by hot filtration.
Typical conditions use 1.2–2.0 equivalents of spray-dried KF, often with tetraphenylphosphonium bromide as a phase-transfer catalyst. Water control is critical: even modest moisture hydrolyzes the aryl fluoride and deactivates KF, so DMSO is dried to ≤ 0.2% before the exchange. The Gould-Jacobs cyclization then closes the 4-quinolone ring in the same high-boiling medium at 150–250 °C, and a final SNAr installs the 7-piperazine side chain at 80–120 °C.
| API | Key DMSO step | Temperature |
|---|---|---|
| Ciprofloxacin | Halex Cl→F; piperazine SNAr | 150–190 / 90–110 °C |
| Levofloxacin | Halex; oxazine closure; piperazine SNAr | 160–200 / 80–120 °C |
| Moxifloxacin | Halex; diazabicyclononane SNAr | 150–190 / 80–120 °C |
| Enrofloxacin | Halex; N-ethylpiperazine SNAr | 150–190 / 90–120 °C |
Table 1: Key DMSO-dependent steps for major fluoroquinolone APIs
Product Routes
Ciprofloxacin and levofloxacin share the same architecture: Halex exchange, condensation with ethoxymethylenemalonate, DMSO cyclization, hydrolysis, then piperazine substitution. Levofloxacin differs by fusing a chiral oxazine ring before piperazine introduction and isolating the single S-enantiomer. Enrofloxacin carries an N-ethylpiperazine, while moxifloxacin uses a bicyclic diazabicyclononane side chain through the same displacement logic.
Why DMSO over Lower-Boiling Alternatives
The Halex stage must reach about 180 °C while keeping corrosive KF in solution, which lower-boiling DMF cannot do without pressure equipment. DMSO solvates the potassium cation and leaves the fluoride bare, accelerating exchange over amide solvents. Hot, fluoride-rich, basic DMSO attacks glass and ordinary stainless steel, so production reactors are built from Hastelloy C or similar nickel alloys. It is a Class 3 solvent under ICH Q3C, and crystallization from water or alcohol brings residuals below the 5000 ppm limit, a value documented in the drug-submission file.
References
- Andriole, G.T. (Ed.) The Quinolones, 3rd ed.; Academic Press: San Diego, 2000.
- Kogon, L.; et al. Process for Preparing Levofloxacin, U.S. Patent 5,576,459; Daiichi Pharmaceutical Co., 1996.
- ICH Harmonised Tripartite Guideline Q3C(R6), 2019.